Fig. 3From: Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancerROC curves showing the sensitivity and specificity, the area under the curve, and the combined effect to assess the diagnostic abilities of peptides and peptide combinations derived from ANT3 and FBLN1 proteins to distinguish between HSIL vs. NC and CC vs. NCBack to article page